1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Global Mental Health Analysis & Statistics (p4)

Global Mental Health Analysis & Statistics (p4)

91-120 of about 1600 reports

Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 35 pages

Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 Summary Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Acute ...

  • World
  • Neurological Disorder
  • Neurology
  • Industry analysis

Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 140 pages

Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021 Summary Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Anxiety Disorders pipeline ...

  • World
  • Neurology
  • Anxiety Disorder
  • Industry analysis

Bipolar Disorder (Manic Depression) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 95 pages

Bipolar Disorder (Manic Depression) (Central Nervous System) - Drugs in Development, 2021 Summary Bipolar Disorder (Manic Depression) (Central Nervous System) - Drugs in Development, 2021 provides an ...

  • World
  • Bipolar Disorder
  • Neurology
  • Industry analysis

Dementia Associated With Alzheimer’s Disease (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 65 pages

Dementia Associated With Alzheimer’s Disease (Central Nervous System) - Drugs in Development, 2021 Summary Dementia Associated With Alzheimer’s Disease (Central Nervous System) - Drugs in Development, ...

  • World
  • Dementia
  • Neurology
  • Industry analysis

Dystonia (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 35 pages

Dystonia (Central Nervous System) - Drugs in Development, 2021 Summary Dystonia (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Dystonia pipeline landscape. The report ...

  • World
  • Neurology
  • Neurological Disorder
  • Industry analysis

Lennox-Gastaut Syndrome (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 45 pages

Lennox-Gastaut Syndrome (Central Nervous System) - Drugs in Development, 2021 Summary Lennox-Gastaut Syndrome (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Lennox-Gastaut ...

  • World
  • Neurology
  • Neurological Disorder
  • Industry analysis

Major Depressive Disorder (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 170 pages

Major Depressive Disorder (Central Nervous System) - Drugs in Development, 2021 Summary Major Depressive Disorder (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Majo ...

  • World
  • Neurology
  • Depression
  • Industry analysis

Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 50 pages

Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 2021 Summary Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 2021 ...

  • World
  • Neurological Disorder
  • Neurology
  • Industry analysis

Primary Progressive Multiple Sclerosis (PPMS) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 55 pages

Primary Progressive Multiple Sclerosis (PPMS) (Central Nervous System) - Drugs in Development, 2021 Summary Primary Progressive Multiple Sclerosis (PPMS) (Central Nervous System) - Drugs in Development, ...

  • World
  • Neurological Disorder
  • Neurology
  • Industry analysis

Relapsing Multiple Sclerosis (RMS) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 45 pages

Relapsing Multiple Sclerosis (RMS) (Central Nervous System) - Drugs in Development, 2021 Summary Relapsing Multiple Sclerosis (RMS) (Central Nervous System) - Drugs in Development, 2021 provides an overview ...

  • World
  • Neurological Disorder
  • Neurology
  • Industry analysis

Relapsing Remitting Multiple Sclerosis (RRMS) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 95 pages

Relapsing Remitting Multiple Sclerosis (RRMS) (Central Nervous System) - Drugs in Development, 2021 Summary Relapsing Remitting Multiple Sclerosis (RRMS) (Central Nervous System) - Drugs in Development, ...

  • World
  • Neurological Disorder
  • Neurology
  • Industry analysis

Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 75 pages

Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021 Summary Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, ...

  • World
  • Neurological Disorder
  • Neurology
  • Industry analysis

Childhood Epilepsy (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Childhood Epilepsy (Central Nervous System) - Drugs in Development, 2021 Summary Childhood Epilepsy (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Childhood Epilepsy ...

  • World
  • Neurology
  • Neurological Disorder
  • Industry analysis

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 65 pages

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) (Central Nervous System) - Drugs in Development, 2021 Summary Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) (Central Nervous System) - Drugs ...

  • World
  • Neurological Disorder
  • Neurology
  • Industry analysis

Generalized Anxiety Disorder (GAD) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 35 pages

Generalized Anxiety Disorder (GAD) (Central Nervous System) - Drugs in Development, 2021 Summary Generalized Anxiety Disorder (GAD) (Central Nervous System) - Drugs in Development, 2021 provides an overview ...

  • World
  • Anxiety Disorder
  • Neurology
  • Industry analysis

Infantile Spasm (West Syndrome) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 35 pages

Infantile Spasm (West Syndrome) (Central Nervous System) - Drugs in Development, 2021 Summary Infantile Spasm (West Syndrome) (Central Nervous System) - Drugs in Development, 2021 provides an overview ...

  • World
  • Neurological Disorder
  • Neurology
  • Industry analysis

Essential Tremor (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 40 pages

Essential Tremor (Central Nervous System) - Drugs in Development, 2021 Summary Essential Tremor (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Essential Tremor pipeline ...

  • World
  • Neurology
  • Neurological Disorder
  • Industry analysis

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in Development, 2021 Summary Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in ...

  • World
  • Neurological Disorder
  • Genetic Disorder
  • Industry analysis

Chronic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Chronic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 Summary Chronic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Chronic ...

  • World
  • Neurological Disorder
  • Neurology
  • Industry analysis

Social Anxiety Disorder (SAD/Social Phobia) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Social Anxiety Disorder (SAD/Social Phobia) (Central Nervous System) - Drugs in Development, 2021 Summary Social Anxiety Disorder (SAD/Social Phobia) (Central Nervous System) - Drugs in Development, 2021 ...

  • World
  • Anxiety Disorder
  • Industry analysis

Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021 Summary Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the A ...

  • World
  • Blood Disease
  • Neurological Disorder
  • Industry analysis

HIV Related Neurological Diseases (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

HIV Related Neurological Diseases (Infectious Disease) - Drugs in Development, 2021 Summary HIV Related Neurological Diseases (Infectious Disease) - Drugs in Development, 2021 provides an overview of ...

  • World
  • Neurological Disorder
  • Infectious Disease
  • Industry analysis

Pituitary Tumor (Oncology) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Pituitary Tumor (Oncology) - Drugs in Development, 2021 Summary Pituitary Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Pituitary Tumor pipeline landscape. The report provides ...

  • World
  • Neurological Disorder
  • Cancer
  • Industry analysis

Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) (Central Nervous System) - Drugs in Development, 2021 Summary Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic ...

  • World
  • Dementia
  • Neurology
  • Industry analysis

Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021 Summary Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Motor Neuron ...

  • World
  • Neurology
  • Neurological Disorder
  • Industry analysis

Spasmodic Torticollis (Cervical Dystonia) (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Spasmodic Torticollis (Cervical Dystonia) (Central Nervous System) - Drugs in Development, 2021 Summary Spasmodic Torticollis (Cervical Dystonia) (Central Nervous System) - Drugs in Development, 2021 ...

  • World
  • Neurology
  • Neurological Disorder
  • Industry analysis

Traumatic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Traumatic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 Summary Traumatic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of the ...

  • World
  • Neurological Disorder
  • Neurology
  • Industry analysis

Barth Syndrome (Genetic Disorders) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Barth Syndrome (Genetic Disorders) - Drugs in Development, 2021 Summary Barth Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Barth Syndrome pipeline landscape. The ...

  • World
  • Genetic Disorder
  • Neurological Disorder
  • Industry analysis

Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) (Musculoskeletal Disorders) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 30 pages

Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Laminin-Deficient Congenital Muscular Dystrophy ...

  • World
  • Neurological Disorder
  • Industry analysis

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorders) - Drugs in Development, 2021

  • $ 2000
  • April 2021
  • 35 pages

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorders) - Drugs in Development, 2021 Summary Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorders) ...

  • World
  • Neurological Disorder
  • Genetic Disorder
  • Industry analysis
About 4300 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Healthcare Trade in Sri Lanka

  • June 2021
  • 32 pages
  • Sri Lanka
  • World
  • Healthcare
  • Vaccine
  • Industry analysis
  • Smoking Prevalence
  • Disability Rate

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on